Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Explore linked clinical trials.9 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Personalized Brain Health Service and Dementia Prevention | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Not applicable | 2026-09-16 | NCT07698431 | |
| PENSA+: Extended Follow-up of a Multimodal Lifestyle Intervention to Prevent Cognitive Decline in APOE-ε4 Carriers | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Not yet recruiting | Not stated | 2026-07-28 | NCT07730671 | |
| DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community | Alzheimer disease, Charcot-Marie-Tooth disease type 1F, Cognition Disorders, Cognitive Dysfunction, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Amyloid, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Not yet recruiting | Not stated | 2026-04-13 | NCT07521722 | |
| Cognitive Remote Assessment Using FLAME (CRA-FLAME) | Cognition Disorders, Cognitive Dysfunction, cognitive disorder, psychiatric disorder | Enrolling by invitation | Not stated | 2025-05-31 | NCT05624632 | |
| β-AARC: Cohort Study for the Identification of Blood-based Biomarkers in a Population With Subjective Cognitive Decline | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, Mild Cognitive Impairment, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Not stated | 2025-05-31 | NCT04935372 | |
| Characterization of Cerebral Tau Aggregates With 18F-RO6958948 PET in the ALFA Population | Cognition Disorders, Cognitive Dysfunction, Mild Cognitive Impairment, cognitive disorder, psychiatric disorder | Enrolling by invitation | Not applicable | 2025-05-31 | NCT04482660 | |
| Longitudinal Study for the Characterization of the Phases of Subjective Perception of Cognitive Decline and Mild Cognitive Impairment of Alzheimer's Disease. | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, Mild Cognitive Impairment, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, subjective cognitive decline, tauopathy | Recruiting | Not stated | 2025-05-31 | NCT03851523 | |
| Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Not stated | 2025-05-31 | NCT02685969 | |
| Early Identification of Markers in Alzheimer's Families / ALFA | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Not stated | 2025-05-31 | NCT02485730 |